Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

Taiwan · Delayed Price · Currency is TWD

57.00

+0.80 (1.42%)

Aug 7, 2026, 1:30 PM CST

13.38% (1Y)

Market Cap	11.20B +7.7%
Revenue (ttm)	7.03B +3.2%
Net Income	964.51M +17.3%
EPS	4.89 +17.0%
Shares Out	196.57M
PE Ratio	11.65
Forward PE	n/a
Dividend	1.82 (3.24%)
Ex-Dividend Date	Jul 23, 2026

Volume	233,163
Open	56.20
Previous Close	56.20
Day's Range	56.20 - 57.30
52-Week Range	48.64 - 60.55
Beta	0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About TPE:1720

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company o... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1967

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 1720

Full Company Profile

Financial Performance

In 2025, TPE:1720's revenue was 7.02 billion, an increase of 3.44% compared to the previous year's 6.79 billion. Earnings were 927.66 million, an increase of 5.36%.

Financial Statements